Data from animal experiments with mechanical circulatory support systems (MCSS) performed in Groningen and Marseille over the past years were used to obtain normal values of hematological, coagulation, rheological and blood chemistry parameters in calves. These parameters were divided between two groups: a limited number of parameters necessary to assess biocompatibility properties of MCSS quickly and a more extensive number of parameters suitable for more detailed biological evaluation of blood pumps. All applied tests can be examined in calf blood as well as in human blood. Parameters were selected on clinical relevance and usefulness for standardization procedures. The obtained data were compared with normal values in human beings derived from the literature.
Al-MondhiryH., PaeW.E.Jr, RosenbergG., PierceW.S.. Hematologic and hemostatic complications associated with long-term use of total artificial heart: clinical and experimental observations.Artif Organs1992; 16: 83–9.
2.
BruggerJ.. Post operative (intensive) care. In: RakhorstG., HoekstraA., eds. Veterinary aspects of animal experiments with heart assist devices. Proceedings of the expert meeting of the Concerted Action Heart 1991, Groningen 18–19 February, ISBN 90-365-0472-4: 49–54.
3.
SharnaC.P., HariP.R.. The effect of anesthetrics and analgetics on protein adsorbtion, platelet adhesion, and plasma recalcification time at blood-polymer interface.Artif Organs1991; 15: 498–506.
4.
EilersR., HarbottP., ReulH., RakhorstG., RauG.. Design improvements of the HIA-VAD based on animal experiments.Artif Organs1994; 18: 7: 473–8.
5.
GrossD.R.. Animal models in cardiovascular research.Dordrecht: Kluwer Academic Publishers, 1994.
KinoshitaM., PantalosG.M., HolfertJ.W.. Animal implantation results with the UTAH-100 total artificial heart.ASAIO J1992; 38: 108–12.
11.
MeliM.. Protocols for in vitro/vivo testing. In: ChiecoS., MambritoB., eds. Concerted action heart; First General Meeting, Rome 1990, ISBN 90-365-0470-8: 41–59.
12.
MontiesJ.R., HavlikP., MesanaT., TrinklJ., TourresJ.L., DemunckJ.L.. Development of the Marseille pulsatile rotary blood pump for permanent implantable left ventricular assistance.Artif Organs1994; 18: 506–11.
13.
MuellerM.R., SchimaH., EngelhardtH.. In vitro hematological testing of rotary blood pumps: remarks on standardization and data interpretation.Artif Organs1993; 17: 103–10.
14.
OlsenD.B., MurrayK.D.. The total artificial heart. In: UngerF., ed. Assisted circulation 2.Berlin: Springer Verlag, 1984: 197–228.
15.
OrimeY., TakataniS., TasaiK.. In vitro and in vivo validation tests for total artificial heart.Artif Organs1994; 18: 54–72.
16.
RakhorstG., HensenA.G., BlanksmaP.K.. Evaluation of a protocol for animal experiments with helmholtz left ventricular assist devices.Cor Europaeum1992; 4: 155–9.
17.
RaoG.H.R., EricsonD.G., WeissD.J., ParksP.G., WhiteJ.G.. Influence of aspirin and carbacyclin on bovine platelet function.ASAIO J1992; 38: 830–4.
18.
SundaramS., CourtneyJ.M., TaggartD.P.. Biocompatibility of cardiopulmonary bypass: influence on blood compatibility of device, mode of blood flow and duration of application.Int J Artif Organs1994; 17: 118–28.
19.
TaenakaY., InoueK., MasuzawaT.. Influence of an impeller centrifugal pump on blood components in chronic animal experiments.ASAIO J1992; 577–9.
20.
Technical Committee ISO/TC 194, Biological evaluation of medical devices. International Standard ISO 10993-1: 1992/ Cor. 1 1992
21.
UtohJ., WhalenR.H., WilkersonB.R., FukamachiK., HarasakiH.. Chronic in vivo function of a new ventricular assist device: the extracorporeal pulsatile assist device (EPAD).Int J Artif Organs1993; 16: 91–5.
22.
Van SwietenH.A.. Temporary bypass systems for cardiac assist. PhD thesis, Utrecht1991; 80–90.
23.
WindbergerU., UrbanekP., VierhapperH.. Diminished release of atrial natriuretic factor in calves with total artificial heart.Artif Organs1992; 16: 392–7.
